CYCN — Cyclerion Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Cyclerion Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	54.4	54	13.4	7.57	3.23
Net Total Accounts Receivable
Net Total Receivables	0.127	0.1	0.096	0	0.556
Prepaid Expenses
Total Other Current Assets
Total Current Assets	58.5	55.5	14.8	8.02	4.22
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	50.3	1.47	1.22	0	0
Long Term Investments
Other Long Term Assets
Total Assets	115	59.3	18.1	13.4	9.57
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	17	11.1	7.63	2.09	0.725
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	55.9	11.1	7.63	2.09	0.725
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	59.5	48.2	10.5	11.3	8.85
Total Liabilities & Shareholders' Equity	115	59.3	18.1	13.4	9.57
Total Common Shares Outstanding
Total Preferred Shares Outstanding